EP Patent

EP1853338A2 — Nasal delivery device

Assigned to Optinose AS · Expires 2007-11-14 · 19y expired

What this patent protects

A nasal delivery device for delivering substance to a nasal cavity of a subject, the delivery device comprising: a substance supply unit (3) for supplying a dose of substance to be delivered to the nasal cavity of the subject, the substance supply unit including an inlet (17) and…

USPTO Abstract

A nasal delivery device for delivering substance to a nasal cavity of a subject, the delivery device comprising: a substance supply unit (3) for supplying a dose of substance to be delivered to the nasal cavity of the subject, the substance supply unit including an inlet (17) and an outlet (19); a nosepiece unit (15) including a nosepiece (30) for fitting to a nasal cavity of the subject and being in fluid communication with the outlet of the substance supply unit,- and a mouthpiece unit (11) including a mouthpiece (25) in fluid communication with the inlet of the substance supply unit and through which the subject in use exhales such as to entrain substance from the container chamber (5) and deliver the same through the nosepiece, and at least one temperature modifier (27) for reducing a temperature of the exhaled air flow such as to reduce the absolute humidity thereof.

Drugs covered by this patent

Patent Metadata

Patent number
EP1853338A2
Jurisdiction
EP
Classification
Expires
2007-11-14
Drug substance claim
No
Drug product claim
No
Assignee
Optinose AS
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.